Occudo Quantitative Strategies’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-97,376
Closed -$1.69M – 725
2026
Q2
$1.69M Sell
97,376
-54,631
-36% -$749K 0.09% 304
2026
Q1
$1.96M Buy
152,007
+123,895
+441% +$1.66M 0.11% 265
2025
Q4
$354K Buy
+28,112
New +$322K 0.02% 463
2025
Q3
– Sell
-45,143
Closed -$365K – 659
2025
Q2
$365K Sell
45,143
-1,871
-4% -$14.1K 0.04% 418
2025
Q1
$389K Buy
+47,014
New +$392K 0.05% 422
2024
Q3
– Sell
-45,150
Closed -$287K – 690
2024
Q2
$287K Sell
45,150
-125
-0.3% -$794 0.05% 476
2024
Q1
$274K Buy
+45,275
New +$255K 0.05% 493
2023
Q4
– Sell
-33,883
Closed -$143K – 784
2023
Q3
$143K Sell
33,883
-86,553
-72% -$323K 0.02% 841
2023
Q2
$373K Buy
120,436
+1,654
+1% +$3.52K 0.04% 662
2023
Q1
$165K Buy
118,782
+57,271
+93% +$114K 0.02% 774
2022
Q4
$122K Buy
61,511
+25,513
+71% +$57.2K 0.01% 832
2022
Q3
$73K Buy
+35,998
New +$101K 0.01% 1065
2021
Q3
– Sell
-31,893
Closed -$163K – 999
2021
Q2
$163K Sell
31,893
-8,271
-21% -$47K 0.02% 745
2021
Q1
$270K Buy
+40,164
New +$223K 0.06% 527

Other funds holding AMRX

Occudo Quantitative Strategies's AMRX Position: Q3 2026 in Review

Occudo Quantitative Strategies sold out of Amneal Pharmaceuticals (AMRX) in Q3 2026, closing a stake of 97,376 shares — an estimated $1.69M sold.

Occudo Quantitative Strategies first reported a position in AMRX in Q1 2021 and held it in 14 quarters. The position peaked at $1.96M in Q1 2026. 332 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Occudo Quantitative Strategies reported no remaining Amneal Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 97,376 Amneal Pharmaceuticals shares in Q3 2026, an estimated $1.69M.
  • Occudo Quantitative Strategies first reported a position in Amneal Pharmaceuticals in Q1 2021 and held it in 14 quarters.
  • Occudo Quantitative Strategies's Amneal Pharmaceuticals position peaked at $1.96M in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2026, filed 16 Nov 2026.